EIF2B3

Translation initiation factor eIF2B subunit gamma · Q9NR50 · EIF2B3 on Sugi Atlas →

0 patent compounds predicted against EIF2B3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to EIF2B3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant PHASE1/PHASE2RECRUITING
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer PHASE1/PHASE2COMPLETED
Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery PHASE2COMPLETED
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Quantification of GADD34 Expression in RA nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Testing of Micellar Casein, Blended Micellar Casein and Native Whey nanCOMPLETED
MEHMO Natural History and Biomarkers nanRECRUITING
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Generating Intervals of Reference FFor Early Life Brain Biomarkers. nanRECRUITING
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study nanRECRUITING
Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour nanUNKNOWN
Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer nanRECRUITING
Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Exploring the Genetics of Neuropathic Pain nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a EIF2B3 binder may also engage these)

ProteinNameSimilarity
P70541 1.000 P70541 →
Q4R6T3 1.000 Q4R6T3 →
A5PJI7 0.997 A5PJI7 →
P80361 0.985 P80361 →
P55232 0.984 P55232 →
P23509 0.982 P23509 →
P55238 0.982 P55238 →
P52416 0.981 P52416 →
P55228 0.981 P55228 →
Q9M2Q4 0.980 Q9M2Q4 →
P56287 0.980 P56287 →
Q42882 0.980 Q42882 →
P15280 0.980 P15280 →
P55233 0.980 P55233 →
P30523 0.979 P30523 →
A7SBF0 0.979 A7SBF0 →
Q86HG0 0.979 Q86HG0 →
Q5Z8Y4 0.978 Q5Z8Y4 →
P55241 0.978 P55241 →
Q6NTR1 0.978 Q6NTR1 →
P56288 0.978 P56288 →
A1DFN6 0.978 A1DFN6 →
P55242 0.977 P55242 →
O74366 0.977 O74366 →
Q9VIK9 0.977 Q9VIK9 →
Q8VY78 0.977 Q8VY78 →
F4I8U2 0.977 F4I8U2 →
Q7TT37 0.977 Q7TT37 →
Q6AY43 0.976 Q6AY43 →
P12299 0.976 P12299 →